Lynparza (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the Lynparza drug offered from AstraZeneca Pharmaceuticals LP. This Poly(ADP-Ribose) Polymerase Inhibitor [EPC],Poly(ADP-Ribose) Polymerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
| NON-PROPRIETARY NAME: | olaparib |
| SUBSTANCE NAME: | OLAPARIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Poly(ADP-Ribose) Polymerase Inhibitor [EPC],Poly(ADP-Ribose) Polymerase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-12-24 |
| END MARKETING DATE: | 0000-00-00 |
Lynparza HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lynparza from AstraZeneca Pharmaceuticals LP |
| LABELER NAME: | AstraZeneca Pharmaceuticals LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2014-12-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0310-0657_2586bfb2-e1a6-41f2-b3ee-f78320a5c6fa |
| PRODUCT NDC: | 0310-0657 |
| APPLICATION NUMBER: | NDA206162 |
Other OLAPARIB Pharmaceutical Manufacturers / Labelers:
